ALSの臨床, 病態と治療

Saved in:
Bibliographic Details
Published in脊髄外科 Vol. 26; no. 3; pp. 270 - 277
Main Author 阿部, 康二
Format Journal Article
LanguageJapanese
Published 日本脊髄外科学会 2012
Subjects
Online AccessGet full text
ISSN0914-6024
1880-9359
DOI10.2531/spinalsurg.26.270

Cover

Author 阿部, 康二
Author_FL ABE Koji
Author_FL_xml – sequence: 1
  fullname: ABE Koji
Author_xml – sequence: 1
  fullname: 阿部, 康二
  organization: 岡山大学大学院医歯薬学総合研究科脳神経内科学
BackLink https://cir.nii.ac.jp/crid/1570572701202419328$$DView record in CiNii
BookMark eNpFkL1KA0EUhQeJ4BrzABaChaUb7_zPlCH-woKFWg8zu5M4S1zDbiwsIwRBH0B8g1QWlvo4wcTHcENEm3OLc_i452yiRnFbeIS2MbQJp_igGobCDqq7st8mok0krKEIKwWxplw3UAQas1gAYRuoVVXBAYCmUjCI0E4nuZiN374fp18fT_u7i5fJfPI8G0_n75-L14cttN6rwb71e5vo6vjosnsaJ-cnZ91OEueESxVzjaVyEnqKMka5zKS1gK2wmoBi4IXIHHfCZym1llGaWS-08A4L5x1xmDbR3opbhGDSsFTMJXBZd8GkfhxrSlQdO1zF8mpk-94My3Bjy3tjy1FIB97872CIMHQpNeDPTq9taXJLfwCNGGEn
ContentType Journal Article
Copyright 2012 日本脊髄外科学会
Copyright_xml – notice: 2012 日本脊髄外科学会
DBID RYH
DOI 10.2531/spinalsurg.26.270
DatabaseName CiNii Complete
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Clinical Features, Pathogenesis, and Therapy for ALS
DocumentTitle_FL Clinical Features, Pathogenesis, and Therapy for ALS
EISSN 1880-9359
EndPage 277
ExternalDocumentID 10031131544
article_spinalsurg_26_3_26_270_article_char_ja
GroupedDBID 123
2WC
ABJNI
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
OK1
RJT
RYH
ID FETCH-LOGICAL-j2578-59178b70f8344357d7aa01a6a920840e66db5b6edc3aa433dae696eb16beb2b13
ISSN 0914-6024
IngestDate Fri Jun 27 00:58:16 EDT 2025
Wed Sep 03 06:11:17 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2578-59178b70f8344357d7aa01a6a920840e66db5b6edc3aa433dae696eb16beb2b13
OpenAccessLink https://www.jstage.jst.go.jp/article/spinalsurg/26/3/26_270/_article/-char/ja
PageCount 8
ParticipantIDs nii_cinii_1570572701202419328
jstage_primary_article_spinalsurg_26_3_26_270_article_char_ja
PublicationCentury 2000
PublicationDate 20120000
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – year: 2012
  text: 20120000
PublicationDecade 2010
PublicationTitle 脊髄外科
PublicationTitleAlternate 脊髄外科
PublicationYear 2012
Publisher 日本脊髄外科学会
Publisher_xml – name: 日本脊髄外科学会
References 14) Yoshino H, Kimura A : Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase Ⅱ study). ALS 7 : 241-245, 2006
13) Abe K, Yuki S, Kogure K : Strong attenuation of ischemic and postischemic brain edema by a novel free radical scavenger. Stroke 19 : 480-485, 1988
21) Habisch HJ, Janowski M, Binder D, et al : Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS : limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm 114 : 1395-1406, 2007
6) Nagai M, Re DB, Nagata T, et al : Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10 : 615-622, 2007
20) Suzuki M, McHugh J, Tork C, et al : GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2 : e689, 2007
3) Urushitani M, Ezzi SA, Matsuo A, et al : The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J 22 : 2476-2487, 2008
16) Mazzini L, Mareschi K, Ferrero I, et al : Autologous mesenchymal stem cells : clinical applications in amyotrophic lateral sclerosis. Neurol Res 28 : 523-526, 2006
5) Urushitani M, Sik A, Sakurai T, et al : Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9 : 108-118, 2006
22) Suzuki M, Svendsen CN : Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci 31 : 192-198, 2008
4) Miyazaki K, Masamoto K, Morimoto N, et al : Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J Cereb Blood Flow Metab 32 : 456-467, 2012
12) Nagano I, Shiote M, Murakami T, et al : Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurol Res 27 : 768-772, 2005
18) Yan J, Xu L, Welsh AM, et al : Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24 : 1976-1985, 2006
10) Tian F, Morimoto N, Liu W, et al : In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis. Autophagy 7 : 985-992, 2011
8) Yamanaka K, Boillee S, Roberts EA, et al : Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci USA 105 : 7594-7599, 2008
7) Yamanaka K, Chun SJ, Boillee S, et al : Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11 : 251-253, 2008
19) Zhao CP, Zhang C, Zhou SN, et al : Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy 9 : 414-426, 2007
1) Nagata T, Nagano I, Shiote M, et al : Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of ALS patients. Neurol Res 29 : 772-776, 2007
2) Nagata T, Ilieva H, Murakami T, et al : Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res 29 : 767-771, 2007
9) Morimoto N, Nagai M, Ohta Y, et al : Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res 1167 : 112-117, 2007
17) Mazzini L, Mareschi K, Ferrero I, et al : Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 265 : 78-83, 2008
11) Nagano I, Ilieva H, Shiote M, et al : Therapeutic benefit of intrathecalinjection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. J Neurol Sci 235 : 61-68, 2005
15) Ohta Y, Nagai M, Nagata T, et al : Intrathecal injection of EGF and FGF2 promotes proliferation of neural precursor cells in the spinal cords of mice with mutant human SOD1 gene. J Neurosci Res 84 : 980-982, 2006
References_xml – reference: 2) Nagata T, Ilieva H, Murakami T, et al : Increased ER stress during motor neuron degeneration in a transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res 29 : 767-771, 2007
– reference: 14) Yoshino H, Kimura A : Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase Ⅱ study). ALS 7 : 241-245, 2006
– reference: 7) Yamanaka K, Chun SJ, Boillee S, et al : Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11 : 251-253, 2008
– reference: 4) Miyazaki K, Masamoto K, Morimoto N, et al : Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J Cereb Blood Flow Metab 32 : 456-467, 2012
– reference: 20) Suzuki M, McHugh J, Tork C, et al : GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2 : e689, 2007
– reference: 10) Tian F, Morimoto N, Liu W, et al : In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis. Autophagy 7 : 985-992, 2011
– reference: 9) Morimoto N, Nagai M, Ohta Y, et al : Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res 1167 : 112-117, 2007
– reference: 22) Suzuki M, Svendsen CN : Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci 31 : 192-198, 2008
– reference: 5) Urushitani M, Sik A, Sakurai T, et al : Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9 : 108-118, 2006
– reference: 13) Abe K, Yuki S, Kogure K : Strong attenuation of ischemic and postischemic brain edema by a novel free radical scavenger. Stroke 19 : 480-485, 1988
– reference: 8) Yamanaka K, Boillee S, Roberts EA, et al : Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci USA 105 : 7594-7599, 2008
– reference: 15) Ohta Y, Nagai M, Nagata T, et al : Intrathecal injection of EGF and FGF2 promotes proliferation of neural precursor cells in the spinal cords of mice with mutant human SOD1 gene. J Neurosci Res 84 : 980-982, 2006
– reference: 12) Nagano I, Shiote M, Murakami T, et al : Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurol Res 27 : 768-772, 2005
– reference: 19) Zhao CP, Zhang C, Zhou SN, et al : Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice. Cytotherapy 9 : 414-426, 2007
– reference: 11) Nagano I, Ilieva H, Shiote M, et al : Therapeutic benefit of intrathecalinjection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. J Neurol Sci 235 : 61-68, 2005
– reference: 1) Nagata T, Nagano I, Shiote M, et al : Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of ALS patients. Neurol Res 29 : 772-776, 2007
– reference: 17) Mazzini L, Mareschi K, Ferrero I, et al : Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 265 : 78-83, 2008
– reference: 6) Nagai M, Re DB, Nagata T, et al : Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10 : 615-622, 2007
– reference: 18) Yan J, Xu L, Welsh AM, et al : Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24 : 1976-1985, 2006
– reference: 16) Mazzini L, Mareschi K, Ferrero I, et al : Autologous mesenchymal stem cells : clinical applications in amyotrophic lateral sclerosis. Neurol Res 28 : 523-526, 2006
– reference: 21) Habisch HJ, Janowski M, Binder D, et al : Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS : limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm 114 : 1395-1406, 2007
– reference: 3) Urushitani M, Ezzi SA, Matsuo A, et al : The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J 22 : 2476-2487, 2008
SSID ssib000937640
ssib002484482
ssib058494343
ssj0046188
ssib000961635
ssib023159666
ssib005901893
Score 1.8631276
SourceID nii
jstage
SourceType Publisher
StartPage 270
SubjectTerms ALS
autophagy
flow-metabolism uncoupling
free radical scavenger
oxidative stress
Title ALSの臨床, 病態と治療
URI https://www.jstage.jst.go.jp/article/spinalsurg/26/3/26_270/_article/-char/ja
https://cir.nii.ac.jp/crid/1570572701202419328
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 脊髄外科, 2012, Vol.26(3), pp.270-277
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELaWcuGCQIAosGgP-EaWxHEc-8DBCakqEEhIrdRbZCdZtHtYqrJ74VakCgkeAPEE9MSBIzxORctjMBNnU_NzaOFiWY49_hnv-BuvZ4aQe2mtuJnEYSCVaQJeG5CDiWgCm1YN6EMTO2FoO_z0mdjc5o93kp3B4JP3amm5sOPq9V_tSv6Fq1AGfEUr2XNwticKBZAH_kIKHIb0TDzGh3dFDGCQ6oIWkoJiryUtEpppKjWuHi1SqlIqE1oITGW2aiCxJGM0y9o6irroPCug2pLjSKVQVGeYB7qaUyWwvoYmPbOwipI028CMjJF223U7jiylBW8HlPs3DNGpJooDgTHqdowqpzo_S-dtySOqRUs-p0r7t44RD0TozKbHjZO5IEICNBD2hbIzo-82X-xLWBdnpDusmYsB8_s5wECyIMd3MbLYq-XeizET477lL-61O-aVp3VLJsoYE2hQrj6jDVw5AyB-EbqM8O3ok-cejgWQJ3ynOUpEvpMfxiX3nQihwa_n9AcwdqI8PRJAIbrt6yEFF1EbQLVfPff3PM7ywR9zBCg1A8UCPUZcmE-nHlraukIud2rOSLt5XSWDmblGhrBfj_Y__3h7-P3ru_ujkw8Hxwfvj_YPj798O_n45jrZ3ii28s2gC88RzFDOBwlo-tKm4QRDtcRJWqfGhJERRrFQ8rARoraJFU1dxcbwOK5NI5QAbCBsY5mN4htkbf5y3twkI0T10tiwhvOBG2NVHVlRWctTy1gdynXy0M2p3HU-WMrzsW2dDGEpymqKaZSkoKRArYjBUqICI2_9J_3b5BL-cNzV3B2ytthbNkMAqwt7t90oPwHexnc4
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ALS%E3%81%AE%E8%87%A8%E5%BA%8A%2C+%E7%97%85%E6%85%8B%E3%81%A8%E6%B2%BB%E7%99%82&rft.jtitle=%E8%84%8A%E9%AB%84%E5%A4%96%E7%A7%91&rft.au=%E9%98%BF%E9%83%A8%2C+%E5%BA%B7%E4%BA%8C&rft.date=2012&rft.pub=%E6%97%A5%E6%9C%AC%E8%84%8A%E9%AB%84%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0914-6024&rft.eissn=1880-9359&rft.volume=26&rft.issue=3&rft.spage=270&rft.epage=277&rft_id=info:doi/10.2531%2Fspinalsurg.26.270&rft.externalDocID=article_spinalsurg_26_3_26_270_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-6024&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-6024&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-6024&client=summon